P-Tweets popular tweeting - jameshebrew - Updates https://old.p-tweets.com/images/membersprofilepic/thumbs/default.jpgP-Tweets popular tweeting - jameshebrew - Updateshttps://old.p-tweets.com/rss_updates.php?id=3004348https://old.p-tweets.com/rss_updates.php?id=3004348 P-Tweets popular tweeting, social networking and microblogging service, tweet twitter like <![CDATA[Cell Therapy Media market Research Report by 2023, Forecast till 2035 Roots Analysis has done a detailed study on Cell Therapy Media, Kits, Reagents and Surfaces Market, 2023-2035, covering key aspects of the industryâs evolution and identifying potential future growth opportunities. Key Market Insights  Leveraging their expertise, over 450 types of kits, media, reagents and extracellular matrices have been manufactured by consumable providers for research and therapeutic purposes  The market features the presence of more than 80 firms across the globe; majority of these stakeholders are emerging players based in North America  A larger proportion of the kits available in the cell therapy domain comprise of different types of reagents; of these, 60% are intended for use with stem cell therapies and nearly 80% are stored in refrigerated conditions  Media developers are offering products for a broad range of cell therapies; nearly 90% of such players are providing media in the volume range of 100 to 500 ml  Predominantly, the cell therapy reagents are intended to be used at discovery scale of operation for a wide spectrum of functions, including cell expansion and proliferation  The market landscape of matrices, which typically have a shelf life of 1 to 1.5 years, is well distributed in terms of type of ECM coating and type of formulation  In pursuit of gaining a competitive edge, cell therapy consumable providers are upgrading their existing technologies and expanding their product portfolios  Many companies have undertaken strategic initiatives, including partnerships, acquisitions and expansions, to augment their existing capabilities  We expect industry stakeholders to continue to forge strategic alliances with niche / specialized players engaged in this domain to further augment their respective product offerings  Over the years, stakeholders within this industry have established strong brand positions by undertaking a range of initiatives to further advance the development of raw materials for cell therapies  Cost is a key determinant for the adoption of consumables in a cell therapy manufacturing process; the pricing strategy matrix is likely to assist players in evaluating the competitive market prices for their products  In 2035, the commercial scale of operation is likely to account for 75% of the total demand for cell therapy surface; this is attributed to the expected surge in the anticipated approvals of multiple cell therapies  A paradigm shift from animal-based to animal component free formulations, combined with stringent regulatory guidelines, is likely to drive the growth of the cell therapy media market at an annualized rate of 12%  The projected future opportunity for cell therapy consumable providers is expected to be well distributed across different types of end-users and key geographical regions Table of Contents 1. PREFACE 1.1. Introduction 1.2. Key Market Insights 1.3. Scope of the Report 1.4. Research Methodology 1.5. Frequently Asked Questions 1.6. Chapter Outlines 2. EXECUTIVE SUMMARY 3. INTRODUCTION 3.1. Context and Background 3.2. Introduction to Cell Therapies 3.3. Comparison of Cell Therapies with Other Biopharmaceuticals 3.4. Classification of Cell Therapy Products 3.5. Overview of Cell Therapy Development and Manufacturing 3.6. Role of Raw Materials in Cell Therapy Development and Manufacturing 3.7. Types of Cell Therapy Consumables 3.8. Key Challenges Associated with Manufacturing of Cell Therapy Consumables 3.9. Future Perspectives 4. MARKET LANDSCAPE 4.1. Chapter Overview 4.2. List of Cell Therapy Kit Providers 4.3. List of Cell Therapy Media Providers 4.4. List of Cell Therapy Reagent Providers 4.5. List of Cell Therapy Extracellular Matrix Providers 5. COMPANY COMPETITIVENESS ANALYSIS 5.1. Chapter Overview 5.2. Key Assumptions and Parameters 5.3. Methodology 5.4. Cell Therapy Consumables Providers: Company Competitiveness Analysis 5.5. Cell Therapy Kits Providers 5.6. Cell Therapy Media Providers 5.7. Cell Therapy Reagent Providers 5.8. Cell Therapy Extracellular Matrix Providers 6. BRAND POSITIONING OF KEY INDUSTRY PLAYERS 6.1. Chapter Overview 6.2. Scope and Methodology 6.3. Brand Positioning: STEMCELL Technologies 6.4. Brand Positioning: Miltenyi Biotec 6.5. Brand Positioning: Thermo Fisher Scientific 6.6. Brand Positioning: Takara Bio 6.7. Brand Positioning: GeminiBio 7. COMPANY PROFILES 7.1. Chapter Overview 7.2. STEMCELL Technologies 7.2.1. Company Overview 7.2.2. Product Portfolio 7.2.3. Recent Developments and Future Outlook 7.3. Miltenyi Biotec 7.4. Thermo Fisher Scientific 7.5. Bio-Techne 7.6. Irvine Scientific 7.7. Lonza 7.8. Sartorius 7.9. BD Biosciences 7.10. Corning 7.11. CellGenix 8. RECENT DEVELOPMENTS AND INITIATIVES 8.1. Chapter Overview 8.2. Partnership Models 8.3. Cell Therapy Consumables: Partnerships and Collaborations 8.4. Cell Therapy Consumables: Mergers and Acquisitions 8.5. Cell Therapy Consumables: Recent Expansions 9. LIKELY PARTNER ANALYSIS FOR CELL THERAPY CONSUMABLE PROVIDERS 9.1. Chapter Overview 9.2. Scoring Criteria and Key Assumptions 9.3. Scope and Methodology 9.4. Key Potential Strategic Partners for Cell Therapy Consumable Providers 10. ROOTS ANALYSIS PRICING STRATEGY 10.1. Chapter Overview 10.2. Roots Analysis Framework 11. DEMAND ANALYSIS 11.1. Chapter Overview 11.2. Scope and Methodology 11.3. Global Demand for Cell Therapy Consumables 11.4. Analysis by Scale of Operation 11.5. Analysis by Geography 12. MARKET FORECAST AND OPPORTUNITY ANALYSIS 12.1. Chapter Overview 12.2. Key Assumptions and Methodology 12.3. Global Cell Therapy Consumables Market, 2023-2035 12.4. Cell Therapy Consumables Market: Analysis by Type of Product 12.5. Cell Therapy Consumables Market: Analysis by Type of Cell Therapy 12.6. Cell Therapy Consumables Market: Analysis by Scale of Operation 12.7. Cell Therapy Consumables Market: Analysis by Type of End-User 12.8. Cell Therapy Consumables Market: Analysis by Geography 13. UPCOMING TRENDS AND FUTURE GROWTH OPPORTUNITIES 13.1. Chapter Overview 13.2. Emerging Trends Related to Cell Culture Media 13.3. Automation of Cell Therapy Manufacturing Processes 13.4. Single Use Systems and Technologies in Cell Therapy Manufacturing 14. CONCLUDING REMARKS 15. INTERVIEW TRANSCRIPTS 16. APPENDIX I: TABULATED DATA 17. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS To view more details on this report, click on the link https://www.rootsanalysis.com/reports/cell-therapy-consumables-market.html Learn from experts: do you know about these emerging industry trends? Unlocking the Potential of Digital Twins in Healthcare: Benefits, Challenges and Opportunities Learn from our recently published whitepaper: - Next Generation Biomanufacturing â The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #CellTherapyMediaMarket #CellTherapyMediaMarketSize #CellTherapyMedia #celltherapysurface #cellcultureconsumables ]]> https://old.p-tweets.com/viewupdate.php?id=172179 https://old.p-tweets.com/viewupdate.php?id=172179


Posted by: jameshebrew
On Wed, 12 Jul 2023 10:15:26 +0000


]]> jameshebrew <![CDATA[Lab Automation market Trends, Analysis by 2035 The âLab Automation Market, 2023-2035â report features an extensive study of the current market landscape and future potential of the lab automation market, over the next 12 years. Key Inclusions  An executive summary of the insights captured during our research, offering a high-level view on the current state of lab automation market and its likely evolution in the mid-to-long term.  A general overview of lab automation, along with details on its historical evolution, different stages and processes. In addition, the chapter presents information on the advantages of lab automation and the challenges associated with its use. Further, it concludes with a discussion on the future perspectives in this domain.  A detailed assessment of the overall market landscape of around 350 lab automation system manufacturers, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, types of lab automation system(s) (automated liquid handling systems (automated integrated workstations, pipetting systems and reagent dispensers), automated microplate systems (automated microplate workstations, microplate washers, multi-mode microplate readers and single-mode microplate readers), automated assay systems, automated nucleic acid extraction systems, robotic systems, automated storage and retrieval systems (ASRS), automated sampling systems and other lab automation equipment), stage(s) of automation (pre-analytical stage, analytical stage, post-analytical stage and total lab automation), application area(s) (drug discovery, diagnostics, genomic solutions, proteomic solutions, microbiology and other applications) and end-user(s) (pharmaceutical and biotechnology companies, research and academic institutes, hospitals and diagnostic laboratories and other end-users).  A detailed competitiveness analysis of lab automation system manufacturers based on several relevant parameters, such as company strength (in terms of number of years since it was established), product diversity (in terms of number of lab automation system being developed by the company) and product strength (in terms of stage(s) of automation, application area(s) and end-user(s)).  Elaborate profiles of key players (shortlisted based on a proprietary criterion) engaged in the development of lab automation systems across North America, Europe and Asia-Pacific and Rest of the World. Each profile features a brief overview of the company, details related to its financial information (if available), product portfolio, recent developments and an informed future outlook.  A detailed analysis of partnerships inked between stakeholders engaged in this domain since 2018, based on several relevant parameters, such as year of partnership, type of partnership, type of partner, type of automation instrument(s), most active players (in terms of number of partnerships) and regional distribution of partnership activity in this domain.  An in-depth analysis of various patents that have been filed / granted related to lab automation since 2018, taking into consideration several relevant parameters, such as patent publication year, type of patent, patent jurisdiction, CPC symbols, type of applicant, emerging focus areas and leading players (in terms of number of patents filled / granted) and leading individual assignees. It also features a detailed patent benchmarking analysis and an insightful valuation analysis, highlighting the leading patents (in terms of number of citations).  Informed estimates of the existing market size and the future opportunity for lab automation instruments, over the next 12 years. Based on multiple parameters, such as global instrumentation market in life science industry, biopharmaceutical industry and share of automation, we have provided informed estimates on the evolution of the market for the period 2023-2035.  A case study on the lab automation software providers, providing detailed analysis on various parameters such as year of establishment, company size (in terms of number of employees), location of headquarters, type of software (laboratory information management system, laboratory information system, electronic lab notebook, scientific data management system and other software), mode(s) of deployment (cloud-based and on-premise), end-user(s) (pharmaceutical and biotechnology companies, research and academic institutes, and hospitals and diagnostic laboratories). The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:  Stage of Automation  Pre-Analytical  Analytical  Post-Analytical  Total Lab Automation  Type of Instrument  Automated Liquid Handling Systems  Automated Microplate Readers  Automated Sampling Systems  Analyzers  Automated Storage and Retrieval Systems (ASRS)  Other Instruments  End-User  Pharmaceutical and Biotechnology Companies  Research and Diagnostic Laboratories  Other End-Users  Key Geographical Regions  North America  Europe  Asia-Pacific  Middle East and North Africa  Latin America Key Questions Answered  What is lab automation?  What is automated liquid handling system? What are examples of liquid handling systems?  How many players are currently involved in the development of lab automation systems?  Which are the top players in the lab automation market?  What is the global market size of the lab automation market?  What is the growth rate of lab automation market?  Which region is likely to hold the largest share in the lab automation market?  What is the market share of automated liquid handling systems?  What are the factors driving the lab automation market? To view more details on this report, click on the link https://www.rootsanalysis.com/reports/lab-automation-market.html News article CAR-T cell therapy market Learn from experts: do you know about these emerging industry trends? Cell Therapy â The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders T-cell Immunotherapies: The Future of Modern Cancer Treatments Learn from our recently published whitepaper: - Next Generation Biomanufacturing â The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #LabAutomationMarket #LabAutomationMarketGrowth #labautomation #laboratoryautomation #laboratoryautomationmarket ]]> https://old.p-tweets.com/viewupdate.php?id=171145 https://old.p-tweets.com/viewupdate.php?id=171145


Posted by: jameshebrew
On Thu, 06 Jul 2023 07:14:57 +0000


]]> jameshebrew <![CDATA[Analysis of Quantum Computing market Strategies and Forecasts to 2035 The âQuantum Computing in Drug Discovery Services Market, 2023-2035â report by Roots Analysis features an extensive study of the current landscape and the likely future potential over the next decade Key Inclusions  A general overview of quantum computing in drug discovery services, along with information on its types and applications across various industries. It also highlights the applications of quantum computing, specifically related to drug discovery. Further, the chapter features a discussion on the challenges, key growth drivers, and future perspectives.  A detailed assessment of the overall market landscape of quantum computing software providers, based on several relevant parameters, including year of establishment, company size (in terms of number of employees), location of headquarters, business capabilities (platform / software, quantum as a service, drug discovery service and in-house pipeline), platform capabilities (drug discovery, drug design, supply chain management and drug development(clinical trials)), type of drug discovery service(s) offered (target discovery / identification, target validation / selection, hit generation / identification / discovery, hit to lead / hit expansion / target to lead / lead identification / select lead series and lead optimization), type of molecule(s) supported (small molecules and large molecules), compatible computational approaches (artificial intelligence and cloud computing), end user(s) (pharmaceutical companies, contract research organizations and academic / research institutes) and therapeutic area(s) (cardiovascular disorders, infectious diseases, neurological disorders , oncological disorders and others)  A detailed competitiveness analysis of quantum computing service providers based on company strength (in terms of years of experience), portfolio strength (in terms of type of drug discovery services offered, type of molecule(s) supported, type of computational approaches and type of end-user(s)), and portfolio diversity (in terms of business capabilities).  Elaborate profiles of quantum computing software providers. Each profile includes a brief overview of the company, financial information (if available), details on service portfolio, recent developments and an informed future outlook.  A detailed assessment of the overall market landscape of quantum computing hardware providers, based on several parameters including year of establishment, company size (in terms of number of employees), location of headquarters, type of offering(s) (hardware as a service and hardware for purchase), data storage on cloud and compatible computational approaches (artificial intelligence and cloud computing)  Detailed profiles of quantum computing hardware providers. Each profile includes a brief overview of the company, financial information (if available), details on service portfolio, recent developments and an informed future outlook.  A detailed review of over 170 academic grants focused on quantum computing in drug discovery, based on several relevant parameters, such as year of grants awarded, amount awarded, support period, type of study section, administering institute center, type of grant, activity code, funding mechanism and amount granted, funding institute and support period, prominent program officers (by number of grants), location of recipient organizations, popular recipient organizations, organization type and amount granted to popular recipient.  A detailed analysis of recent partnerships inked between stakeholders engaged in this domain, since 2017, based on several relevant parameters, such as year of partnership, type of partnership, most active players (in terms of number of partnerships), and regional distribution of partnership activity in this domain.  A use case study highlighting the applications of quantum computing across various industries, such as chemical industry, cybersecurity, financial modeling, space sciences, oil and gas industry and weather forecasting, and its likely evolution in the foreseen future.  A qualitative analysis, highlighting the five competitive forces prevalent in this domain, including threats for new entrants, bargaining power of buyers, bargaining power of suppliers, threats of substitute product and rivalry among existing competitors.  A detailed analysis of the current and future market based on blue ocean strategy, covering a strategic plan / guide for emerging players in this domain to help unlock an uncontested market, featuring thirteen strategic tools that can help software providers to shift towards a blue ocean strategic market.  One of the key objectives of the report was to estimate the current opportunity and future growth potential of quantum computing in drug discovery services market over the coming years. We have provided informed estimates on the likely evolution of the market for the period, 2023-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as drug discovery services offered (target identification / validation, hit generation / lead identification and lead optimization), therapeutic area (cardiovascular disorders, CNS disorders, dermatological disorders, endocrine disorders, gastrointestinal disorders, immunological disorders, infectious diseases, musculoskeletal disorders, oncological disorders, respiratory disorders and others), and key geographical regions ((North America (US and Canada), Europe (UK, France, Germany and Rest of the Europe), Asia-Pacific (China, Japan and Rest of the Asia Pacific), Latin America and Middle East and North Africa). In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industryâs evolution. By 2035, the financial opportunity within the tissue engineering-based regeneration devices has been analyzed across the following segments:  Drug Discovery Service(s) Offered  Target Identification / Validation  Hit Generation / Lead Identification  Lead Optimization  Therapeutic Area  Cardiovascular Disorders  CNS Disorders  Dermatological Disorders  Endocrine Disorders  Gastrointestinal Disorders  Immunological Disorders  Infectious Diseases  Musculoskeletal Disorders  Oncological Disorders  Respiratory Disorders  Others  Geographical Regions  North America  Europe  Asia-Pacific  Latin America  MENA Key Questions Answered  What is quantum computing and how does it work in drug discovery?  What is the current market landscape of the quantum computing market focused on drug discovery?  What are the key trends across grants awarded for quantum computing in drug discovery?  What are the key trends in the partnerships and collaborations for quantum computing in drug discovery?  What is the impact of quantum computing on the pharmaceutical industry?  What is the market size of quantum computing in drug discovery services market?  Who are the players in the quantum computing in drug discovery services market? To view more details on this report, click on the link https://www.rootsanalysis.com/reports/quantum-computing-in-drug-discovery.html News article Biopharmaceutical Filtration Market Learn from experts: do you know about these emerging industry trends? SARM1: A Potential Therapeutic Target For Neurodegenerative Diseases Medical Device Coatings and Modification Technologies About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #quantumcomputingcompanies #quantumcomputingreport #quantumcomputingsoftware ]]> https://old.p-tweets.com/viewupdate.php?id=170605 https://old.p-tweets.com/viewupdate.php?id=170605


Posted by: jameshebrew
On Mon, 03 Jul 2023 11:44:57 +0000


]]> jameshebrew <![CDATA[Patient Recruitment Services and Patient Retention Services market Size, Share, Trends by 2035 The recruitment of suitable clinical trial participants is often fraught with several challenges, including scientific and operational complexity, insufficient resources and expertise, issues related to data handling and increasingly stringent regulatory guidelines. As a result, outsourcing has become a popular operating model in this domain, as it enables reduction in costs, optimization of timelines and launch of respective offerings, as per planned timelines. In fact, several patient recruitment firms have begun adopting and implementing modern technical strategies, such as social media platforms, mobile applications, Electronic Health Records (EHRs) and Real-World Evidence (RWE) for patient enrolment. The USD 26.2 billion (by 2035) financial opportunity within the patient recruitment and retention services market has been analyzed across the following segments:  Patient Recruitment Step  Pre-screening  Screening  Trial Phase  Phase I  Phase II  Phase III  Phase IV  Therapeutic Area  Cardiovascular Disorders  Oncological Disorders  Infectious Diseases  CNS Disorders  Respiratory Disorders  Hematological Disorders  Dermatological Disorders  Ophthalmic Disorders  Others  Key Geographical Regions  North America  Europe  Asia Pacific  Latin America  Middle East and North Africa  Rest of the World The Patient Recruitment Services and Patient Retention Services Market (3rd Edition), 2022-2035 report features the following companies, which we identified to be key players in this domain:  BBK Worldwide  Continuum Clinical  IQVIA  United BioSource (UBC)  WCG ThreeWire  Clariness  Fidelis Research  Ignite Data  Innovative Trials  Orphan Reach  3H Medi Solution  Buzzreach  Current Medical Information Center (CMIC)  nRollmed  Trialfacts Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Patient Outreach Methods 5. Market Landscape 6. Patient Retention and Patient Recruitment Companies Competitiveness Analysis 7. Company Profiles: Patient Recruitment and Patient Retention Services Providers in North America 8. Company Profiles: Patient Recruitment and Retention Services Providers in Europe 9. Company Profiles: Patient Recruitment and Retention Services Providers in Asia-Pacific and Rest of The World 10. Partnerships and Collaborations 11. Recent Trends in Patient Recruitment and Retention 12. Future Growth Opportunities in Patient Recruitment 13. Case Study: Regulatory Landscape of Patient Recruitment 14. Patient Recruitment in Trials Focused on Personalized Medicines and Rare Diseases 15. Analysis of Demand for Clinical Trial Participants 16. Market Sizing and Opportunity Analysis 17. Concluding Remarks 18. Executive Insights 19. Appendix 1: Tabulated Data 21. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market/245.html News article Biopharmaceutical Filtration Market Learn from experts: do you know about these emerging industry trends? mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends Exploring How Artificial Intelligence Is Transforming Digital Pathology About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #PatientRecruitmentServicesandPatientRetentionServicesMarket #PatientRecruitmentServicesandPatientRetentionServicesMarketSize #patientrecruitment #clinicaltrialpatientrecruitment #clinicaltrialrecruitment ]]> https://old.p-tweets.com/viewupdate.php?id=170136 https://old.p-tweets.com/viewupdate.php?id=170136


Posted by: jameshebrew
On Thu, 29 Jun 2023 10:14:45 +0000


]]> jameshebrew <![CDATA[Latest news on Bacteriophage therapy market Research Report by 2035 Bacteriophage Therapy is an attractive approach to tackle the escalating resistance against antibiotics; over the years, this upcoming class of target specific therapeutic agents has generated significant enthusiasm within the medical science community Roots Analysis has announced the addition of âBacteriophage Therapeutics Market, 2022-2035â report to its list of offerings. The report features an extensive study on the current market landscape, offering an informed opinion on the likely evolution and future opportunities associated with the bacteriophage therapeutics market. The study underlines an in-depth analysis, highlighting the key drivers and the market trends related to this evolving segment of the pharmaceutical industry. Amongst other elements, the report includes:  A summary of the key insights from the bacteriophage therapeutics market. It offers a high-level view on the current state of the market and its likely evolution in the mid to long term.  A general overview of the historical evolution of bacteriophages and their biology. It also includes a detailed discussion on applications of bacteriophage therapy. The chapter concludes with a discussion on the various advantages and limitations associated with the bacterio-phage therapy.  A detailed overview of the overall market landscape of bacteriophage therapeutics, including information on their current status of development, key therapeutic areas, type of bacterial strain, target disease indication, type of therapy, route of administration, and information on bacteriophage related technologies.  An overview of the current status of the market with respect to the players engaged in the manufacturing of bacteriophage therapeutics, featuring information on the year of establishment, company size, location of headquarters, and leading developers.  Elaborate profiles of the prominent players engaged in the development of bacteriophage therapeutics.  An in-depth analysis of completed, ongoing and planned clinical studies, based on several relevant parameters, such as trial registration year, trial phase, enrolled patient population, study design, type of sponsor / collaborator, most active players, registered trials, and geographical region.  An in-depth analysis of the various patents that have been filed / granted related to bacteriophage therapeutics. It includes information on key parameters. It also highlights the leading industry and non-industry players and individual assignees.  An in-depth analysis of various publications for bacteriophage therapeutics, based on several relevant parameters, such as year of publication, type of article, popular keywords, most popular publishers, key journals. It also highlights benchmarking of the publications to develop more insightful opinions on the recent trends related to research and development in this area.  A detailed study of the various grants that have been awarded to research institutes engaged in projects related to bacteriophage therapeutics, since 2017, highlighting various important parameters.  An in-depth analysis of the investments made, including grants, venture capital financing, initial public offering, secondary offering, private placement, equity and debt funding, at various stages of development, in companies that are focused on developing bacteriophage therapeutics.  A detailed study of the recent collaborations and partnership established in this domain since 2017, including the details of deals that were / are focused on the development of bacteriophage therapeutics.  An analysis of the various start-ups engaged in the development of bacteriophage therapeutics, based on relevant parameters, such as pipeline strength, pipeline maturity, indication diversity, number of patents, financial support and partnership activity The financial opportunity within the bacteriophage therapeutics market has been analyzed across the following segments:  Type of Therapeutic Area  Gastrointestinal Infections  Bacterial Dysentery  Multiple Infections  Other Infections  Distribution by Route of Administration  Oral Route  Rectal Route  Intravesical Route  Topical Route  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa Key Companies covered in the report  Adaptive Phage Therapeutics  ContaFect  Eliava BioPreparations  Micreos  NPO Microgen  Phagelux  Pherecydes Pharma For additional details, please visit https://www.rootsanalysis.com/reports/bacteriophage-therapy-market.html You may also be interested in the following titles: Bispecific Antibodies Market Novel Cell Cytometers: Need of the Hour Bispecific Antibodies Market Roots Analysis Consulting - the preferred research partner for global firms About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #BacteriophagetherapymarketGrowth #BacteriophagetherapymarketTrends #bacteriophagetherapeutics #phagetherapy #bacteriophagemarket ]]> https://old.p-tweets.com/viewupdate.php?id=169721 https://old.p-tweets.com/viewupdate.php?id=169721


Posted by: jameshebrew
On Tue, 27 Jun 2023 05:22:35 +0000


]]> jameshebrew <![CDATA[Medical Device coating market Size, Share, Trends by 2035 The growing demand for complex medical devices has prompted developers to innovate and introduce biocompatible, high-performance medical device coatings that can meet the operational, clinical, and engineering requirements for these devices. Presently, multiple types of medical device coating are available in the market to accommodate the multifunctionality of novel medical devices. A detailed medical device coating market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):  Type of Devices Coated  Class I Medical Devices  Class II Medical Devices  Class III Medical Devices  Type of Coating Material  Polymer Coatings  Metal Coatings  Other Coatings  Company Size  Very Small  Small  Mid-sized  Large  Very Large  Key Geographical Region  North America  Europe  Asia  Rest of the World Key companies covered in the report  Advanced Coating  Biocoat  Evonik  Formacoat  Harland Medical Systems  Para-Coat Technologies  Specialty Coating Systems  SurModics  TUA Systems Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Medical Device Coating Providers: Market Landscape 5. Company Competitiveness Analysis 6. Surface Modification Technologies and Coating Solutions: Market Landscape 7. Product Competitiveness Analysis 8. Medical Device Coating Providers: Company Profiles 9. Partnerships and Collaborations 10. Medical Device Coating Providers: Pestle Analysis 11. Market Forecast 12. Concluding Remarks 13. Executive Insights 14. Appendix 1: Tabulated Data 15. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/medical-device-coatings-market.html You may also be interested in the following titles: Nanoparticle Formulation Market 4D Bioprinting Market: Key Trends Global Digital Therapeutics Market Roots Analysis Consulting - the preferred research partner for global firms About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #MedicalDevicecoatingMarketSize #medicaldevicecoating #medicaldevicecoatingmarket #medicalcoatingcompanies #medicalcoatings ]]> https://old.p-tweets.com/viewupdate.php?id=168708 https://old.p-tweets.com/viewupdate.php?id=168708


Posted by: jameshebrew
On Mon, 19 Jun 2023 12:35:11 +0000


]]> jameshebrew <![CDATA[Cell Therapy Media market Size, Share, Trends by 2035 The âCell Therapy Media, Kits, Reagents and Surfaces Market, 2023-2035â report by Roots Analysis features an extensive study of the current market landscape and the likely future potential of the cell culture media (supplied alone or in kits as a combination with cell growth supplements), cell culture reagents and ECM market, over the next 12 years. Key Inclusions  An executive summary of the insights captured during our research, offering a high-level view on the current state of the cell therapy consumables market and its likely evolution in the mid-long term.  A general introduction to cell therapies, including details related to the development and manufacturing of such therapeutics products, with addition focus on role of raw materials in cell therapy production. It further provides a brief overview of the different types of cell therapy consumables and key challenges associated with their development.  A detailed assessment of the overall market landscape of companies offering cell therapy consumables, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of product (kits, media, reagents and extracellular matrices), number and location of consumable facilities, accreditations received, type of end-user (industry and non-industry), media compatibility (serum free , xeno free and both), type of cell therapy (T-cell therapies, stem cell therapies, NK cell therapies, dendritic cell therapies and others), type of function (cell proliferation, cell expansion, cell differentiation, cell activation, cell isolation, cell attachment), kit components (supplements / reagents, growth / induction medium, expansion medium, differentiation medium and others), type of ECM coating (laminin, fibronectin, vitronectin, basement membrane extract and others), type of formulation (powder, liquid, pre-coated cultureware), shelf life (6-12 months, 13-18 months, 19-24 months and 25-36 months), scale of operation (discovery, preclinical, clinical and commercial), application area (research use and therapeutic use), storage temperature (refrigerated, frozen, ultra-low and room temperature), as well as volume of media, reagents and extracellular matrices.  A detailed competitiveness analysis of cell therapy consumables providers (kits, media, reagents and extracellular matrices) based on supplier strength (in terms of years of experience and company size), portfolio strength (considering media compatibility, number of unique type of cell therapy, application area, product manufacturing practices and number of consumable facilities) and number of products offered.  A detailed brand positioning analysis of prominent industry players (shortlisted on the basis of strength of service portfolio), highlighting the current perceptions regarding their proprietary brands across different consumable classes.  Elaborate profiles of key players offering cell therapy consumables (shortlisted on the basis of portfolio strength and number of products offered); each profile includes a brief overview of the company, along with information on its cell therapy consumables focused product portfolio, consumable facilities, recent developments and an informed future outlook.  An analysis of recent developments within the cell therapy consumable industry, highlighting information on several partnerships and collaborations, mergers and acquisitions, and expansion initiatives that have taken place within this domain, during the period 2016-2022.  A list of over 250 cell therapy developers that are anticipated to partner with cell therapy consumable providers; these players have been shortlisted based on several relevant parameters, such as developer strength (which takes into account a companyâs size and its experience in this field), pipeline strength and maturity (based on the number of pipeline drugs and affiliated stage of development), and availability of other cell therapy capabilities.  A proprietary Roots Analysis competitive pricing framework, which analyzes the competitive position of various companies engaged in this domain, by taking into consideration the prices and features of their consumable offerings (such as media and extracellular matrices). In addition, it presents an equation devised to calculate the likely price of cell therapy consumables based upon their characteristics.  An informed estimate of the annual demand for cell therapy consumables (in terms of volume of media required for total number of cells), based on scale of operation and key geographical regions.  An in-depth discussion on the upcoming trends and future growth opportunities within the cell therapy consumables market, featuring details related to the significance of automation in cell therapy manufacturing processes and benefits of single use technologies for production of cell therapies. The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:  Type of Product  Media  Kits  Reagents  Extracellular Matrices  Type of Cell Therapy  T-cell Therapy  Stem Cell Therapy  Dendritic Cell Therapy  NK Cell Therapy  Scale of Operation  Clinical  Commercial  Type of End User  Industry  Non-Industry  Key Geographical Regions  North America  Europe  Asia-Pacific  Middle East and North Africa  Latin America Key Questions Answered  What are the factors driving the cell therapy consumables market?  How many players are engaged in offering cell culture media for manufacturing cell therapies?  How many players are engaged in offering kits for manufacturing cell therapies?  How many media products are available in the market for culturing cell therapies?  What are the partnership and collaboration trends observed in the cell therapy consumables domain?  Which geographical segment captures the largest market share in the current cell therapy consumables market?  Which type of product contributes to the largest share of the cell therapy consumables market? To view more details on this report, click on the link https://www.rootsanalysis.com/reports/cell-therapy-consumables-market.html You may also be interested in the following titles: Conjugation and Labeling Services Market Bispecific Antibodies Market AI-based digital pathology market long-acting drug delivery technologies market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #CellTherapyMediaMarket #CellTherapyMediaMarketSize #consumables #consumablesproducts #cellcultureconsumables ]]> https://old.p-tweets.com/viewupdate.php?id=168113 https://old.p-tweets.com/viewupdate.php?id=168113


Posted by: jameshebrew
On Thu, 15 Jun 2023 06:13:58 +0000


]]> jameshebrew <![CDATA[Fill Finish Biopharmaceuticals market Growth Analysis and Forecast by 2035 A number of biopharmaceutical companies are outsourcing their biologics fill / finish operations, thereby, prompting stakeholders engaged in this domain to undertake several expansion initiatives, to cater to the needs of clients around the globe. Roots Analysis has announced the addition of âBiologics Fill / Finish Services Market (3rd Edition), 2022 â 2035â report to its list of offerings The report features an extensive study on the extensive study of the current landscape and the likely future potential of biologics fill / finish services market, over the next decade. The study also features an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field. In addition to other elements, the study includes:  A detailed review of the overall landscape of the companies offering fill finish services for biopharmaceuticals / biologics, along with analyses based on a number of relevant parameters, such as year of establishment, company size, location of headquarters, location of fill / finish facilities, type of packaging container(s) used, type of biologic(s) involved, scale of operation, type of additional drug product-related service(s) offered and including details related to companies.  A detailed competitiveness analysis of the biologics fill / finish service providers headquartered in different geographies and offering services across various packaging container(s), based on supplier strength, service strength and service diversity.  Elaborate profiles of key players based in North America, Europe and Asia-Pacific. Each profile provides an overview of the company, information on its service offerings, fill / finish facilities, financial information (if available), details on partnerships, expansions, recent awards and accolades, and an informed future outlook.  A detailed analysis of the various partnerships and collaborations established by stakeholders in this domain since 2013. It includes a brief description of the partnership models adopted by stakeholders in this domain. Further, it comprises of analysis based on year of partnership, scale of operation, type of service(s) offered, type of biologic(s) involved, type of process(es) involved and location of the facilities / headquarters. It also highlights the most active players (in terms of number of partnerships) in the domain.  A detailed analysis of the expansions undertaken by various service providers to enhance biologics fill / finish capabilities, based on various parameters, including year of expansion, type of expansion, geographical location of the facility, type of packaging container(s) involved, scale of operation (as mentioned in the expansion terms), type of service(s) offered, type of biologic(s) involved, and expansion details (in terms of new area added to the existing facilities). It also highlights the most active players (in terms of number of instances) in the domain.  A comprehensive analysis of the global biologics fill / finish capacity, by taking into consideration the container processing capacities of various fill / finish service providers (as available on respective company websites). The global biopharmaceutical fill / finish capacity has been distributed across number of packaging units, type of packaging container, company size of the manufacturer, scale of operation and location of headquarters and location of fill / finish facility.  An estimate of the annual demand for fill / finish for biologics (in terms of number of units of packaging container), based on various relevant parameters, such as target patient population, dosing frequency, dose strength, type of packaging container and volume of the packaging container of the abovementioned products.  An analysis on the key performance indicators of service providers based on the information available for top ten biopharmaceutical players on various public platforms, as well as inputs obtained from primary research.  A regional capability assessment framework, which compares the biologics fill / finish capability across key geographies, based on a number of parameters, such as the number of biologics fill / finish service providers, number of biologics fill / finish facilities, number of biologics fill / finish partnerships inked in that particular geographical region, number of facility expansions and installed biologic fill / finish capacity in that particular geographical region.  A discussion on the potential growth drivers for the biologics fill / finish services market, takes into consideration the opportunities associated with the growing biopharmaceutical pipeline, increase in outsourcing of fill / finish operations, rising focus on self-administration of drugs / therapies and opportunities in the Asia-Pacific region.  A case study focused on use of robotic systems in fill / finish operations. It provides a list of equipment used by the service providers (wherever specified) for fill / finish operations, highlighting the purpose of robotics in various manufacturing operations. It also includes a list of companies providing robots for use in manufacturing processes carried in the pharmaceutical sector  A case study on the use of ready-to-use packaging components in the aseptic fill / finish operations. It also provides a list of suppliers providing ready-to-use components. The financial opportunity within the biologics fill / finish services market has been analyzed across the following segments:  Type of Packaging Container  Ampoules  Cartridges  Syringes  Vials  Type of Biologic  Antibodies  Cell Therapies  Gene Therapies  Oligonucleotides  Proteins / Peptides  Vaccines  Others  Therapeutic Area  Oncological Disorders  Autoimmune Disorders  Infectious Diseases  Cardiovascular Disorders  Other Disorders  Scale of Operation  Preclinical / Clinical  Commercial  Company Size  Large  Mid-sized  Small  Key Geographical Regions  North America  Europe  Asia-Pacific  Middle East and North Africa  Latin America Key Companies covered in the report  AbbVie Contract Manufacturing  Asymchem  BioReliance  Boehringer Ingelheim BioXcellence  Catalent Biologics  Charles River Laboratories  Fareva  Fresenius Kabi  Glaxo SmithKline  Hetero Drugs  Intas Pharmaceuticals  Lonza  Patheon  Pierre Fabre  Recipharm  Samsun Biologics  Syngene  Takara Bio  Wacker Biotech  WuXi AppTec  WuXi Biologics To view more details on this report, click on the link https://www.rootsanalysis.com/reports/view_document/biologics-fill-finish-services-market/256.html You may also be interested in the following titles: Cannabis Testing Market Decentralized Clinical Trials / Virtual Clinical Trials Market Global digital twins market Quantum computing in drug discovery services market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #FillFinishBiopharmaceuticalsMarketGrowth #FillFinishBiopharmaceuticalsMarketTrends #biologicsfillfinish #finishservicesmarket #BiologicsPackaging ]]> https://old.p-tweets.com/viewupdate.php?id=167781 https://old.p-tweets.com/viewupdate.php?id=167781


Posted by: jameshebrew
On Tue, 13 Jun 2023 07:06:36 +0000


]]> jameshebrew <![CDATA[Lab Automation market Trend and Market Forecast 2035 Roots Analysis has done a detailed study on lab automation market, 2023-2035 covering key aspects of the industryâs evolution and identifying potential future growth opportunities. Key Market Insights  Presently, around 350 players claim to have the necessary capabilities to offer several lab automation systems, catering to the needs of various end-users within the healthcare industry  More than 90% of the lab automation system manufacturers are focusing on pre-analytical stage-based instruments; of these, automated liquid handling systems and automated analysis systems have been more widely adopted by pharma and biotech companies  In pursuit of gaining a competitive edge, companies are actively enhancing their existing capabilities to enhance their respective product portfolios and drive compliance to evolving industry benchmarks  The partnership activity has increased at a CAGR of around 25%; in fact, the maximum deals related to lab automation have been inked in the last three years  More than 6,200 patents related to lab automation have been filed / granted recently, highlighting the growing interest in scalable and configurable lab automation systems  Majority of the lab automation software providers are headquartered in North America; more than 55% of the market is captured by small players  The increasing adoption of lab automation in the healthcare industry is anticipated to create profitable business opportunities for lab automation software providers  The market is estimated to grow at an annualized rate of ~15%; the opportunity is likely to be well distributed across various types of instruments, geographical regions, stages of automation and end-users Table of Contents 1. PREFACE 1.1. Introduction 1.2. Key Market Insights 1.3. Scope of the Report 1.4. Research Methodology 1.5. Frequently Asked Questions 1.6. Chapter Outlines 2. EXECUTIVE SUMMARY 3. INTRODUCTION 3.1. Overview of Lab Automation 3.2. Historical Evolution of Lab Automation 3.3. Stages of Lab Automation 3.4. Process of Lab Automation 3.5. Advantages of Lab Automation Over Manual Handling 3.6. Challenges associated with Lab Automation 3.7. Future Perspectives 4. MARKET LANDSCAPE 4.1. Lab Automation System Manufacturers: Overall Market Landscape 4.1.1. Analysis by Year of Establishment 4.1.2. Analysis by Company Size 4.1.3. Analysis by Location of Headquarters 4.1.4. Analysis by Company Size and Location of Headquarters 4.1.5. Analysis by Type of Lab Automation System(s) 4.1.6. Analysis by Type of Automated Liquid Handler(s) 4.1.7. Analysis by Type of Automated Microplate(s) 4.1.8. Analysis by Stage(s) of Automation 4.1.9. Analysis by Application Area(s) 4.1.10. Analysis by Type of Lab Automation System(s) and Application Area(s) 4.1.11. Analysis by End-user(s) 4.1.12. Analysis by Stage(s) of Automation and End-user(s) 5. COMPANY COMPETITIVENESS ANALYSIS 5.1. Assumptions and Key Parameters 5.2 Methodology 5.3. Competitiveness Analysis: Very Small Companies based in North America (Peer Group I) 5.4. Competitiveness Analysis: Small Companies based in North America (Peer Group II) 5.5 Competitiveness Analysis: Mid-sized Players based in North America (Peer Group III) 5.5. Competitiveness Analysis: Large Companies based in North America (Peer Group IV) 5.6. Competitiveness Analysis: Very Large Companies based in North America (Peer Group V) 5.7 Competitiveness Analysis: Very Small Companies based in Europe (Peer Group VI) 5.8 Competitiveness Analysis: Small Companies based in Europe (Peer Group VII) 5.9. Competitiveness Analysis: Mid-sized Companies based in Europe (Peer Group VII) 5.10. Competitiveness Analysis: Large Companies based in Europe (Peer Group IX) 5.11. Competitiveness Analysis: Very Large Companies based in Europe (Peer Group X) 5.12. Competitiveness Analysis: Very Small Companies based in Asia-Pacific and Rest of the World (Peer Group XI) 5.13. Competitiveness Analysis: Small Companies based in Asia-Pacific and Rest of the World (Peer Group XII) 5.14. Competitiveness Analysis: Mid-sized Companies based in Asia-Pacific and Rest of the World (Peer Group XIII) 5.15. Competitiveness Analysis: Large Companies based in Asia-Pacific and Rest of the World (Peer Group XIV) 5.16. Competitiveness Analysis: Very Large Companies based in Asia-Pacific and Rest of the World (Peer Group XV) 6. COMPANY PROFILES 6.1. Abbott 6.1.1. Company Overview 6.1.2. Financial Information 6.1.3. Lab Automation Product Portfolio 6.1.4. Recent Developments and Future Outlook 6.2. Anton Paar 6.3. BD 6.4. Beckman Coulter 6.5. ERWEKA 6.6. Leuze 6.7. Ortho Clinical Diagnostics 6.8. Pall Corporation 6.9. PerkinElmer 6.10. Roche Diagnostics 6.11. Siemens Healthineers 6.12. SYSTAG 7. PARTENRSHIPS AND COLLABORATIONS 7.1. Partnership Models 7.2. Lab Automation: List of Partnerships and Collaborations 8. PATENT ANALYSIS 8.1. Methodology and Key Parameters 8.2. Lab Automation: List of Patents 8.3. Analysis by Patent Publication Year 8.4. Analysis by Publication Year and Type of Patent 8.5. Analysis by Application Year 8.6. Analysis by Patent Jurisdiction 8.7. Analysis by CPC Symbols 8.8. Analysis by Type of Applicant 8.9. Word Cloud: Emerging Focus Areas 8.10. Analysis by Patent Age 8.11. Leading Industry Players: Analysis by Number of Patents 8.12. Leading Non-Industry Players: Analysis by Number of Patents 8.13. Leading Individual Assignees: Analysis by Number of Patents 8.14. Patent Benchmarking: Analysis of Leading Industry Players by Patent Characterization (CPC Symbols) 8.15. Patent Valuation: Methodology and Key Parameters 9. MARKET FORECAST AND OPPORTUNITY ANALYSIS 9.1. Methodology and Key Assumptions 9.2. Global Lab Automation Market, 2023-2035 9.2.1. Lab Automation Market: Distribution by Stage of Automation, 2023 and 2035 9.2.2. Lab Automation Market: Distribution by Type of Instrument, 2023 and 2035 9.2.3. Lab Automation Market: Distribution by End-user, 2023 and 2035 9.2.4. Lab Automation Market: Distribution by Key Geographical Regions, 2023 and 2035 10. CASE STUDY: LAB AUTOMATION SOFTWARE 10.1. Lab Automation Software Providers: Overall Market Landscape 10.1.1. Analysis by Year of Establishment 10.1.2. Analysis by Company Size 10.1.3. Analysis by Location of Headquarters 10.1.4. Analysis by Company Size and Location of Headquarters 10.1.5. Analysis by Type of Software 10.1.6. Analysis by Mode(s) of Deployment 10.1.7. Analysis by Type of Software and Mode(s) of Deployment 10.1.8. Analysis by End-user(s) 10.1.9. Analysis by Type of Software and End-user(s) 11. EXECUTIVE INSIGHTS 11.1. Chapter Overview 11.2. Africa Medical Supplies Platform 11.3. A.S.T. Biomedical 11.4. Berthold Technologi 11.5. Efevre Tech 11.6. HSE 11.7. Inheco 11.8. LabWare 11.9. SciRobotics 12. APPENDIX 1: TABULATED DATA 13. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS To view more details on this report, click on the link https://www.rootsanalysis.com/reports/lab-automation-market.html You may also be interested in the following titles: Digital Therapeutics Market Global TIL Therapies Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #LabAutomationMarketSize #LabAutomationMarketTrends #LabautomationSystem #microplatereaders #LaboratoryInformationManagementSystem(LIMS) ]]> https://old.p-tweets.com/viewupdate.php?id=167173 https://old.p-tweets.com/viewupdate.php?id=167173


Posted by: jameshebrew
On Wed, 07 Jun 2023 05:54:47 +0000


]]> jameshebrew <![CDATA[Latest news on TIL Therapies market Research Report by 2035 Given the limitations associated with conventional cancer treatment options, there has been a surge in the need for more effective, safe and versatile alternatives, such as TIL-based therapies. Driven by a promising development pipeline and encouraging clinical trial results, the TIL-based therapy market is likely to carve out a significant share of the cancer immunotherapy market. The financial opportunity within the TIL-based therapy market has been analyzed across the following segments:  Target Indication(s)  Melanoma  Head and Neck Carcinoma  Chronic Lymphocytic Leukemia  Sarcoma  Hepatocellular Carcinoma  Breast Cancer  Acute Myeloid Leukemia  Cervical Carcinoma  Key Geographical Regions  North America  Europe  Asia Pacific  Latin America  Middle East and North Africa  Rest of the World The Global TIL Therapy Market (2nd Edition), 2023-2035 report features the following companies, which we identified to be key players in this domain:  Cellectis  Cellular Biomedicine Group  Iovance Biotherapeutics  Lytix Biopharma  Phio Pharmaceuticals Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. TIL-based Therapies: Market Landscape 5. Clinical Trial Analysis 6. Key Opinion Leaders 7. TIL-based Therapy Profiles 8. Partnerships And Collaborations 9. Funding And Investment Analysis 10. Patent Analysis 11. Case Study: Cell Therapy Manufacturing 12. Cost Price Analysis 13. Market Forecast and Opportunity Analysis 14. Company Profiles 15. Concluding Remarks 16. Executive Insights 17. Appendix I: Tabulated Data 18. Appendix II: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/til-therapies-market.html You may also be interested in the following titles: Decentralized Clinical Trials / Virtual Clinical Trials Market Global Antibiotics Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #TILTherapiesMarketSize #TILTherapiesMarketGrowth #TILimmunotherapies #TILbasedproducts #TILMarket ]]> https://old.p-tweets.com/viewupdate.php?id=166557 https://old.p-tweets.com/viewupdate.php?id=166557


Posted by: jameshebrew
On Fri, 02 Jun 2023 05:49:47 +0000


]]> jameshebrew <![CDATA[Viral Clearance and Viral Testing Services market Growth Opportunity and Industry Forecast to 2035 With the growing pipeline of biologics and the continuous revision of regulatory guidelines, the demand for viral clearance and testing services has increased in the biopharmaceutical industry. As a result, biopharmaceutical developers are outsourcing their viral clearance and testing operations to reliable and specialized contract research organizations (CROs), which provide a plethora of advanced technologies and dedicated expertise to cater to their evolving needs. The financial opportunity within the viral clearance and testing services market has been analyzed across the following segments:  Scale of Operation  Discovery Phase  Preclinical Phase  Clinical Phase  Method of Viral Clearance and Testing  Viral Detection  Viral Inactivation  Viral Removal  End-User  Biotechnology and Pharmaceutical Companies  Academic / Research Institutes  Key Geographical Regions  North America  Europe  Asia-Pacific  Rest of the World The âViral Clearance and Viral Testing Services Market, 2023 â 2035â report features the following companies, which we identified to be key players in this domain:  Charles River Laboratories  Eurofins Scientific  Microbac Laboratories  Nelson Labs  Pall Corporation  Syngene International  Texcell Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Viral Clearance and Testing Service Providers: Market Landscape 5. Company Competitiveness Analysis 6. Viral Clearance and Testing Service Providers in North America 7. Viral Clearance and Testing Service Providers in Europe and Asia-Pacific 8. Patent Analysis 9. Recent Developments 10. Viral Clearance and Testing Services: Market Forecast and Opportunity Analysis 11. Conclusion 12. Executive Insights 13. Appendix 1: Tabulated Data 14. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/viral-clearance-and-testing-services-market.html You may also be interested in the following titles: DNA and Gene Cloning Services Market mRNA Synthesis and Manufacturing Services Market You may also like to learn what our experts are sharing in Roots educational series: Monkeypox: Disease Overview, Transmission and Diagnosis Antiviral Drugs Development: Are we Prepared for the Next Viral Pandemic? About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #ViralClearanceandViralTestingServicesMarketTrends #ViralClearanceandViralTestingServicesMarketShare #viralinactivation #viraltesting #viralclearance ]]> https://old.p-tweets.com/viewupdate.php?id=166015 https://old.p-tweets.com/viewupdate.php?id=166015


Posted by: jameshebrew
On Tue, 30 May 2023 06:21:30 +0000


]]> jameshebrew <![CDATA[Smart Labels market Size, Share, Trends by 2035 Pharmaceutical smart labels offer functionality and connectivity, along with providing an interactive and real-time solution, across the overall supply chain Roots Analysis has announced the addition of âSmart Pharmaceutical and Healthcare Labels Market, 2022-2035â report to its list of offerings. The report features an extensive study of the current market landscape and future opportunities associated with the smart pharmaceutical and healthcare labels, offering in-depth analyses of the various business entities engaged in this domain, across key global regions. Request a free sample of the report https://www.rootsanalysis.com/reports/smart-labels-market/request-sample.html Amongst other elements, the report includes:  A brief overview of smart labels, along with the information on their role and advantages in healthcare sector, along with details on the types of smart labels, featuring their applications in the pharmaceutical and healthcare domain. In addition, it includes a discussion on various challenges associated with the adoption of smart labels, future perspectives, and the factors driving the smart pharmaceutical and healthcare labels industry.  A detailed review of the overall landscape of players engaged in the smart pharmaceutical and healthcare label providers domain, along with information on type of technology, RFID frequency band and area(s) of application.  A detailed competitiveness analysis of companies engaged in the development of smart pharmaceutical and healthcare labels, based on their supplier strength, service strength and portfolio strength.  Elaborate profiles of prominent players that claim to specialize in offering smart pharmaceutical and healthcare labels. Each profile features a brief overview of the company, along with information on their year of establishment, number of employees, location of headquarters, key executives, as well as details related to their smart labels focused portfolio, recent developments and an informed future outlook.  An in-depth analysis of patents related to smart pharmaceutical and healthcare labels that have been filed / granted till date, based on several relevant parameters, such as type of patent, publication year, geographical location / patent jurisdiction, legal status, CPC symbols, type of industry, type of applicant and leading players (in terms of number of patents filed / granted). In addition, it features a patent valuation analysis which evaluates the qualitative and quantitative aspects of the patents filed / granted in this industry.  A detailed analysis of the partnerships and collaborations inked in the domain, during the period 2018-2022, based on several parameters, such as year of partnership, type of partnership, most active player and region.  A detailed analysis of the current and future market based on blue ocean strategy, covering a strategic plan / guide for emerging players in this domain to help unlock an uncontested market, featuring thirteen strategic tools that can help software developers to shift towards a blue ocean strategic market.  A detailed discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution, along with a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall smart pharmaceutical and healthcare labels market.  The financial opportunity within the smart labels market has been analyzed across the following segments:  Type of Technology  RFID  NFC  Other Technologies  Type of packaging  Primary Packaging  Secondary Packaging  Type of Primary Packaging  Vials  Syringes  Cartridges  Ampoules  Bottles  Blister Packs  Type of Secondary Packaging  Boxes  Cartons  Pouches  Key Geographical Regions  North America  Europe  Asia-Pacific  MENA  Latin America To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/smart-labels-market.html You may also be interested in the following titles: Cell Therapy Manufacturing Market Global TCR Therapy Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com Smart Labels Market, Smart Labels Market Growth, Healthcare Labels, Smart Labels, NFC ]]> https://old.p-tweets.com/viewupdate.php?id=165791 https://old.p-tweets.com/viewupdate.php?id=165791


Posted by: jameshebrew
On Mon, 29 May 2023 04:18:49 +0000


]]> jameshebrew <![CDATA[Blockchain technology in healthcare market Analysis and Trends by 2022-2035 Given the potential of blockchain to optimize process timelines, while ensuring data privacy and integrity, this technology has garnered significant attention within the pharmaceutical industry Roots Analysis is pleased to announce the publication of its recent study, titled, âBlockchain Technology in Healthcare Industry (Focus on Drug Discovery and Clinical Trials Market), 2023-2035â report to its list of offerings. The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report includes:  An executive summary of the insights captured during our research.  A general overview of blockchain, along with information on the type of blockchain, advantages and future perspective.  A detailed assessment of the overall market landscape of blockchain technology providers.  A competitiveness analysis of Blockchain Technology Providers, based on supplier strength, portfolio diversity and portfolio strength.  Elaborate profiles of prominent players providing blockchain technology, across North America, Europe and Asia-Pacific.  An analysis of the partnerships that have been established in this domain, in the recent past.  A detailed review of more than 500 peer-reviewed, scientific articles related to research on blockchain.  A discussion on affiliated trends, key drivers, and challenges under a SWOT framework.  A case study highlighting the applications of blockchain across various industries.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):  Type of Blockchain  Public Blockchain  Private Blockchain  Hybrid Blockchain  Other Blockchains  Type of End-User  Hospitals  Pharmaceutical Industry  Research Institutes  Academic Institutes  Key Geographical Regions  North America  Europe  Asia-Pacific  Rest of the World Key companies covered in the report  Alten Calsoft Labs  ConsenSys  Humanscape  Hyperledger Foundation  IBM  Infosys  Innoplexus  Medsphere  Solulab  Stratumn  Tech Mahindra To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/blockchain-technology-in-healthcare-market.html You may also be interested in the following titles: Cell Therapy Manufacturing Market Global TCR Therapy Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #BlockchaintechnologyinhealthcareMarket #BlockchaintechnologyinhealthcareMarketGrowth #BlockchainTechnology #blockchain #blockchainindustry ]]> https://old.p-tweets.com/viewupdate.php?id=165577 https://old.p-tweets.com/viewupdate.php?id=165577


Posted by: jameshebrew
On Fri, 26 May 2023 06:52:44 +0000


]]> jameshebrew <![CDATA[Digital Biomanufacturing market Research Report by 2022, Forecast till 2035 Upon realizing the potential of digital biomanufacturing over traditional processes, players are actively undertaking initiatives to adopt advanced platforms to drive operational excellence, visibility, control and synchronization in bioprocessing Roots Analysis is pleased to announce the publication of its recent study, titled, âDigital Biomanufacturing Market, 2023-2035.â The report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different regions. Amongst other elements, the report includes:  An executive summary of the insights captured during our research, offering a high-level view on the current state of the digital biomanufacturing market and its likely evolution in the mid-long term.  A general introduction to digital biomanufacturing, featuring a detailed discussion on various types of technologies that support digital bioprocessing. In addition, it presents the key challenges and future perspectives associated with the employment of digital technologies in the field of biomanufacturing.  A detailed assessment of the overall market landscape of companies offering digital biomanufacturing technologies (PAT, DAS, MES and digital twins), based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of company (CDMO provider and software provider), number of platforms offered, deployment options (cloud based, on-premises, corporate datacenter and hybrid), platform capabilities (process automation, bioprocess optimization and controls, process connectivity, scalability, data integration, process monitoring and visualization, performance analysis, report generation and documentation, smart manufacturing, document control, production tracking, performance analysis and data integration), software capabilities (process intelligence, data integration, real-time process monitoring, data visualization, performance analysis and control prediction, reporting and data management), type(s) of biologic(s) manufactured, other compatible platforms (artificial intelligence / machine learning / cloud based, big data, internet of things, augmented reality and virtual reality) and type of end user(s) (industry and non-industry), integrating software (enterprise resource planning (ERP), manufacturing operation management (MOM), product lifecycle management (PLM), human resource management (HRM)), type of service(s) offered (training, implementation / upgradation and general support), area(s) of application (asset / process management, clinical trials, personalized treatment, medical training, surgical planning, health monitoring and diagnosis).  A detailed competitiveness analysis of digital biomanufacturing technologies (PAT, DAS, MES and digital twins), based on supplier strength (in terms of years of experience and company size), technology portfolio (considering deployment options, number of platform capabilities, type of end user(s), software capabilities, area(s) of application, type(s) of twin(s)) and type(s) of biologic(s) manufactured.  Elaborate profiles of key players (companies offering more than one platform and established before 2012) engaged in the digital biomanufacturing domain, which are actively providing software based on PAT, DAS, MES and digital twins. Each profile includes a brief overview of the company, along with information on capabilities of digital technologies offered by these firms, recent developments and an informed future outlook.  A benchmark analysis highlighting the capabilities of companies (in terms of their expertise across various platforms related to the manufacturing of biologics) engaged in this domain, across key peer groups.  An analysis featuring information on recent partnerships inked between stakeholders engaged in this domain, based on several relevant parameters, such as year of partnership, type of partnership, type of technology, most active players (in terms of number of deals inked) and regional distribution of partnership activity, during the period 2018-2022.  A detailed analysis highlighting the market concentration of key industry stakeholders (companies offering more than one platform) across various regions, based on prevalent parameters, such as years of entrance, company size, type of technology, number of platforms offered and number of partnerships inked.  A detailed industry lifecycle analysis that indicates various stages, including emergence, growth, maturation and eventual decline for the digital biomanufacturing industry. The primary purpose of this analysis is to develop a better understanding of the current position / phase of the industry on the lifecycle chart (based on historical trends, partnership activity and various investments made by players engaged in this domain) and predict the upcoming events that are likely to drive the growth of this domain. Further, it presents short-term and long-term impacts of various key parameters that are expected to highly impact the wider adoption of digitalization in the field of biomanufacturing.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Type of Technology  Process Analytical Technology (PAT)  Data Analysis Software (DAS)  Manufacturing Execution Systems (MES)  Digital Twins  Deployment Options  Cloud-based Deployment Options  On-premises Deployment Options  Type(s) of Biologic(s) Manufactured  Antibodies  Cell and Gene Therapies  Proteins  Vaccines  Others  Geographical Regions  North America  Europe  Asia Pacific  Latin America  Middle East and North America Key companies / organizations covered in the report  AspenTech  Bioreactors.net  Dassault SystÃmes  FUJIFILM Diosynth Biotechnologies  GE Healthcare  KÃrber  Merck  Sartorius  Thermo Fisher Scientific To view more details on this report, click on the link https://www.rootsanalysis.com/reports/digital-biomanufacturing-market.html You may also be interested in the following titles: Decentralized Clinical Trials / Virtual Clinical Trials Market Global Antibiotics Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #DigitalBiomanufacturingMarket #DigitalBiomanufacturingMarketSize #DigitalBiomanufacturing #bioprocesssimulationsoftware #bioprocessing4.0 ]]> https://old.p-tweets.com/viewupdate.php?id=165287 https://old.p-tweets.com/viewupdate.php?id=165287


Posted by: jameshebrew
On Wed, 24 May 2023 06:57:42 +0000


]]> jameshebrew <![CDATA[mRNA Synthesis and Manufacturing Services market Research Report by 2022, Forecast till 2035 Given the current technical and operational challenges associated with the manufacturing of mRNA-based products, innovators in the biopharmaceutical industry are increasingly relying on the mRNA synthesis and contract manufacturing service providers Roots Analysis is pleased to announce the publication of its recent study, titled, âmRNA Synthesis and Manufacturing Services Market (2nd Edition), 2022â2035â The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report includes  A general overview of mRNA, highlighting details on its structure, the evolution of mRNA vaccines, manufacturing processes and commonly outsourced manufacturing operations.  A detailed assessment of the overall market landscape of the companies offering mRNA custom synthesis services.  A detailed competitiveness analysis of mRNA custom synthesis service providers.  A comprehensive assessment of the overall market landscape of mRNA contract manufacturing service providers, based on several relevant parameters.  An in-depth company competitiveness analysis of mRNA contract manufacturing service providers based in North America, Europe and Asia-Pacific.  A detailed overview of the current market landscape of kits available for synthesis of research grade mRNA.  A detailed product competitiveness analysis of the mRNA synthesis kits.  Elaborate profiles of key players engaged in the synthesis and manufacturing of mRNA (shortlisted based on strength of service portfolio).  Detailed profiles of the key mRNA synthesis kit providers (shortlisted based on strength of product portfolio).  A detailed assessment of completed, ongoing and planned clinical studies of mRNA therapeutics and vaccines.  An insight analysis of the recent partnerships inked between stakeholders engaged in this domain from 2014-2022  An in-depth analysis of over 35 mRNA-based therapeutics / vaccines developers that are likely to partner with mRNA contract manufacturing service providers.  A review of the various mRNA-focused initiatives undertaken by big pharma players (shortlisted on the basis of the revenues generated in 2021)  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Type of Product  Drug substances (APIs)  Drug products (FDFs)  Application Area  mRNA-based vaccines  mRNA-based therapeutics  Therapeutic Area  Infectious diseases  Oncological disorders  Other diseases  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa  Rest of the World Key companies covered in the report.  Aldevron  APExBIO  Biomay  bioSYNTHESIS  CELLSCRIPT  eTheRNA  Eurogentec  Jena Biosciences  New England Biolabs  Thermo Fisher Scientific  TriLink BioTechnologies To view more details on this report, click on the link https://www.rootsanalysis.com/reports/mrna-synthesis-and-manufacturing-market.html You may also be interested in the following titles: Cannabis Testing Market Decentralized Clinical Trials / Virtual Clinical Trials Market You may also like to learn what our experts are sharing in Roots educational series: Cell Therapy â The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders 4D Bioprinting Market: Key Trends About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #mRNASynthesisandManufacturingServicesMarket #mRNASynthesisandManufacturingServicesMarketSize #mRNAsynthesisservices #mRNAsynthesisandmanufacturingservices #mRNAbasedproducts ]]> https://old.p-tweets.com/viewupdate.php?id=164992 https://old.p-tweets.com/viewupdate.php?id=164992


Posted by: jameshebrew
On Mon, 22 May 2023 08:03:47 +0000


]]> jameshebrew <![CDATA[Cell and gene therapy CRO market 2022 â Industry Growth by 2035 In the last few years, many contract research organizations (CROs) have emerged and significantly impacted the overall biopharmaceutical market. It is worth mentioning that the presence of CROs has enabled small and mid-sized companies, which lack the necessary expertise and elaborate resources, to successfully initiate R&D programs in several domains. The financial opportunity within the Cell and Gene Therapy CROs Market has been analyzed across the following segments:  Area of Expertise  Cell Therapy  Gene Therapy  Scale of Operation  Preclinical  Clinical  Drug Discovery  Therapeutic Area  Oncological Disorders  Neurological Disorders  Cardiovascular Disorders  Infectious Diseases  Metabolic Disorders  Autoimmune Disorders  Blood Disorders  Rare / Genetic Disorders  Ophthalmic Disorders  Other disorders  Analysis by Geographical Regions  North America  Europe  Asia Pacific  Latin America  Middle East and North Africa The Cell and Gene Therapy CROs Market, 2022-2035 report features the following companies, which we identified to be key players in this domain:  Altasciences  Charles River Laboratories  Creative Biolabs  IQVIA  Medpace  PPD  Precision for Medicine  Accelera  Evotec  ICON  Syneos Health  CMIC Group  Labcorp Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Guide To Outsourcing 5. Market Landscape 6. Company Profiles 7. Competitive Benchmarking 8. Partnerships And Collaborations 9. Mergers and Acquisitions 10. Key Acquisition Targets 11. Likely Partner Analysis for Cell Therapy CROs 12. Likely Partner Analysis for Gene Therapy CROs 13. Clinical Trial Analysis 14. Total Cost of Ownership for Cell and Gene Therapy Contract Research Organizations 15. Market Forecast and Opportunity Analysis 16. Swot Analysis 17. Conclusion 18. Interview And Survey Transcripts 19. Appendix 1: Tabulated Data 20. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/view_document/cell-and-gene-therapy-cros-market/230.html You may also be interested in the following titles: Womenâs Digital Health Market Modular Manufacturing Facilities Market You may also like to learn what our experts are sharing in Roots educational series: Is Blue Ocean Strategy The Silver Bullet For Emerging Teleradiology Players to Achieve A Breakthrough In This Highly Competitive Market? Artificial Intelligence (AI) In Oncology: Current Scenario And Future Potential About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #CellandgenetherapyCROMarket #CellandgenetherapyCROMarketGrowth #Geneandcelltherapy #cellandgenetherapycro #cellandgenetherapies ]]> https://old.p-tweets.com/viewupdate.php?id=164789 https://old.p-tweets.com/viewupdate.php?id=164789


Posted by: jameshebrew
On Fri, 19 May 2023 09:50:59 +0000


]]> jameshebrew <![CDATA[Automatic Sampling market Professional Survey Report by 2035 The rising demand for improved aseptic handling, greater reproducibility and reduced errors have prompted the biopharmaceutical companies to consider shifting from manually operated sampling systems to automatic sampling systems Roots Analysis is pleased to announce the publication of its recent study, titled, âAutomatic Sampling in Biopharmaceutical Applications and the Measurement of CQA, 2022-2035â report to its list of offerings. The report features an extensive study on the current and future potential of automatic sampling systems. Due to the growing demand for biologics and stringent regulatory guidelines, the biopharmaceutical industry has shifted to using automatic sampling methods, which offer reliable systems for transferring bioprocess samples directly from bioreactors to analytical devices while maintaining the process sterility and integrity. In addition, it features an elaborate discussion on the likely opportunity for the players engaged in this domain, over the next decade. Amongst other elements, the automatic sampling market report includes:  A detailed assessment of the current market landscape of automatic sampling systems and their manufacturers.  A competitiveness analysis of automatic sampling systems manufacturers.  Elaborate profiles of prominent players engaged in the manufacturing of automatic sampling systems (shortlisted on the basis of company size).  A detailed market landscape of automatic sample collection / preparation systems and their manufacturers.  Detailed profiles of the players offering automatic sample collection / preparation systems (shortlisted on the basis of the number of systems manufactured).  An insightful analysis of the patents filed / granted for automatic sampling systems, since 2016.  An analysis of various developments / recent trends related to automatic sampling systems.  A discussion on affiliated trends, key drivers and challenges, under a SWOT framework.  A qualitative analysis, highlighting the five competitive forces prevalent in the automatic sampling domain.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):  Type of Monitoring Method  On-line  Off-line  At-line  Bioprocessing Method  Upstream  Downstream  Working Volume  Less than 10 mL  10-50 mL  51-100 mL  More than 100 mL  Scalability  Lab  Pilot  Commercial  Key Geographical Regions  North America  Europe  Asia-Pacific and Rest of the World Key companies covered in the report  Agilent Technologies  Cytiva  Mettler Toledo  Pall Corporation  Shimadzu  Xylem To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/automatic-sampling-market.html You may also be interested in the following titles: Gene Switch Market Digital Biomanufacturing Market You may also like to learn what our experts are sharing in Roots educational series: Antiviral Drugs Development: Are we Prepared for the Next Viral Pandemic? Exploring How Artificial Intelligence Is Transforming Digital Pathology About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com #AutomaticSamplingMarket #AutomaticSamplingMarketSize #automaticsamplinginbiopharmaceuticals #asepticsampling #samplingmarket ]]> https://old.p-tweets.com/viewupdate.php?id=164456 https://old.p-tweets.com/viewupdate.php?id=164456


Posted by: jameshebrew
On Wed, 17 May 2023 07:05:42 +0000


]]> jameshebrew <![CDATA[CAR-T Cell Therapy market Professional Survey Report by 2035 As the six approved CAR-T cell therapies, including BreyanziÂ, Abecmaâ and CARVYKTIâ are poised to achieve blockbuster status, along with a promising development pipeline, the field of CAR-T cell therapies has gained significant traction Roots Analysis is pleased to announce the publication of its recent study, titled, âGlobal CAR-T Cell Therapy Market (4th Edition), 2022-2035.â The study features an in-depth analysis of key drivers and trends related to this domain. Amongst other elements, the report includes:  A detailed assessment of the current market landscape of CAR-T-cell therapies.  An analysis of key insights derived from the study featuring a competitive analysis, highlighting the popular target antigens related to hematological malignancies and solid tumors.  A detailed analysis of completed, ongoing and planned clinical studies related to CAR-T cell therapies.  An insightful analysis highlighting the key opinion leaders (KOLs) in this domain featuring an analysis of the various principal investigators of clinical trials related to CAR-T cell therapies.  Elaborate profiles of marketed and mid- to late-stage clinical products (phase I/II or above).  An analysis of various type of partnership that have been inked between several stakeholders in the domain of CAR-T-cell therapies.  An analysis of the investments that have been made into companies that have proprietary CAR-T cell-based products / technologies.  An in-depth analysis of patents related to CAR-T cell therapies, filed / granted till 2022.  A case study on manufacturing cell therapy products, highlighting the key challenges, and a detailed list of contract service providers and in-house manufacturers involved in this space.  An elaborate discussion on various factors that form the basis for the pricing of cell-based therapies.  A review of the key promotional strategies being adopted by the developers of the approved CAR-T cell therapies.  Elaborate profiles of the several leading players in the domain of CAR-T cell therapies. A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):  Target Indication(s)  Non-Hodgkinâs Lymphoma  Multiple Myeloma  Acute Lymphoblastic Leukemia  Chronic Lymphocytic Leukemia  Hodgkinâs Lymphoma  Acute Myeloid Leukemia  Ovarian Cancer  Generalized Myasthenia Gravis (MG)  Renal Cell Carcinoma  Target Antigen  CD19  BCMA  CD19/22  Others  Key Geographical Regions  North America  Europe  Asia Pacific  Latin America  Middle East and North Africa  Rest of the World Transcripts of interviews held with the following senior level representatives of stakeholder companies:  Troels Jordansen (Chief Executive Officer, Glycostem Therapeutics)  Wei (William) Cao (Chief Executive Officer, Gracell Biotechnologies)  Miguel Forte (Chief Operating Officer, TxCell)  Adrian Bot (Vice President, Scientific Affairs, Kite Pharma)  Vincent Brichard (Vice President, Immuno-Oncology, Celyad)  Brian Dattilo (Manager of Business Development, Waisman Biomanufacturing)  Aino Kalervo (Former Competitive Intelligence Manager, Strategy & Business Development, Theravectys)  Xian-Bao Zhan (Professor of Medicine and Director, Department of Oncology, Changhai Hospital)  Enkhtsetseg Purev (Assistant Professor of Medicine, University of Colorado) The research includes profiles of key players (listed below); each profile features a brief overview of the company, details related to its financial information (if available), details about CAR-T-cell based product(s), such as information on type of therapy and current development status, information on technology portfolio (if available), recent developments related to CAR-T cell immunotherapies and manufacturing capabilities of the players.  Autolus  bluebird Bio  Bristol Myers Squibb  Carsgen Therapeutics  Cellectis  Cellular Biomedicine Group  Gilead Sciences  Innovative Cellular Therapeutics  Kuur Therapeutics  Noile-Immune Biotech  Novartis  Shanghai GeneChem  Sinobioway Cell Therapy  Takara Bio  Wellington Zhaotai Therapies Get more details on the CAR-T Cell Therapy Market report https://www.rootsanalysis.com/reports/view_document/car-t-therapies-market/269.html You may also be interested in the following titles: DNA Encoded Libraries Quantum Computing in Drug Discovery Services Market You may also like to learn what our experts are sharing in Roots educational series: mRNA Synthesis: Manufacturing Process of Modern Revolutionary Molecule TIL Therapies: A New Paradigm in Cancer Treatment About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #CARTcelltherapyMarket #CARTcelltherapyMarket Size #CARTcellth0erapyMarketGrowth #CARTcelltherapies #ChimericAntigenReceptor ]]> https://old.p-tweets.com/viewupdate.php?id=164163 https://old.p-tweets.com/viewupdate.php?id=164163


Posted by: jameshebrew
On Mon, 15 May 2023 08:05:30 +0000


]]> jameshebrew <![CDATA[TIL Therapies market Growth Analysis by 2035 The âGlobal TIL-based Therapy Market (2nd Edition), 2023-2035â report features an extensive study of the current market landscape and future potential of TIL-based therapies over the next decade. Key Inclusions  An executive summary of the insights captured during our research. It offers a high-level view on the current state of global TIL therapies market and its likely evolution in the mid-long term.  A general overview of TIL-based therapies in comparison to conventional forms of therapy that are being used for the treatment of various oncological indications. Further, it includes historical evolution of cancer immunotherapy, general manufacturing procedure of T-cell immunotherapies, and key attributes in the development of TIL-based therapies.  A detailed assessment of the overall market landscape of TIL-based therapies, based on several relevant parameters, such as type of developer (industry and non-industry), phase of development (preclinical, phase I, phase I/II, phase II, phase III and approved), therapeutic area (hematological cancer, solid tumor and others), target indication (melanoma, ovarian cancer, cervical cancer, lung cancer, pancreatic cancer, sarcoma, breast cancer, squamous cell carcinoma, fallopian tube cancer, gastric cancer, head and neck squamous cell carcinoma and others), source of T-cells (autologous and allogeneic), route of administration (intravenous and hepatic arterial infusion), dosing frequency (single dose and multiple dose), target patient segment (children, adults and seniors), and type of therapy (monotherapy and combination therapy). Further, the chapter also provides developer landscape of industry and non-industry players engaged in this domain.  An analysis of completed, ongoing, and planned clinical studies related to TIL-based therapies, based on several relevant parameters, such as trial registration year, enrolled patient population, trial status, trial phase, target patient segment, type of sponsor / collaborator, study design, most active players (in terms of number of registered trials), key focus areas and geography.  An insightful analysis highlighting the key opinion leaders (KOLs) in this domain, featuring an analysis of the various principal investigators of clinical trials related to TIL-based therapies, considering them to be KOLs, who are actively involved in R&D of TIL-based therapies. In addition, it compares the relative expertise of KOLs based on a proprietary scoring criterion with that of a third party.  Elaborate profiles of mid- to late-stage clinical products (phase I/II or above); each profile features an overview of the therapy, its mechanism of action, dosage information, details on the cost and sales information (wherever available), a clinical development plan, and clinical trial results.  A detailed analysis of recent partnerships inked between several stakeholders engaged in this domain, covering R&D agreements, license agreements (specific to technology platforms and product candidates), manufacturing agreements, clinical trial collaborations and others.  An analysis of the funding and investments that have been made into companies having proprietary TIL-based products / technologies, including venture capital financing, capital raised from Initial Public Offerings (IPOs) and subsequent offerings, grants, and debt financing.  An in-depth analysis of patents related to TIL-based therapies, filed / granted till 2022, based on several relevant parameters, such as type of patent (granted and patent applications), patent publication year, geographical distribution, type of player, Cooperative Patent Classification (CPC) symbols, emerging focus areas, leading players (in terms of number of patents), and patent benchmarking. In addition, it features a patent valuation analysis, which evaluates the qualitative and quantitative aspects of the patents.  A case study on manufacturing cell therapy products, highlighting the key challenges, and a detailed list of contract service providers and in-house manufacturers involved in this space.  An elaborate discussion on various factors that form the basis for the pricing of cell-based therapies. It features different models / approaches that a pharmaceutical company may choose to adopt to decide the price of a TIL-based therapy that is likely to be marketed in the coming years.  Elaborate profiles of the leading players in the domain of TIL-based therapies. Each company profile includes an overview of the developer and a brief description of the product portfolio specific to TIL-based therapies, the technology portfolio (if available), recent developments related to TIL-based therapies, and the manufacturing capabilities of the companies. Additionally, we have provided details of the strategic / venture capital investments made in these companies. The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:  Target Indication(s)  Cellectis  Cellular Biomedicine Group  Iovance Biotherapeutics  Lytix Biopharma  Phio Pharmaceuticals  Key Geographical Regions  North America  Europe  Asia Pacific  Latin America  Middle East and North Africa  Rest of the World Key Questions Answered  What is the growth rate of TIL-based therapy market?  Which region has the highest growth rate in the TIL-based Therapies market?  How many players are developing TIL-based Therapies?  Which target indication covers the largest TIL-based therapy market share?  What is the partnership and collaboration trend in the TIL-based therapy domain?  What is the current IP landscape of TIL-based therapies market? To view more details on this report, click on the link https://www.rootsanalysis.com/reports/til-therapies-market.html You may also be interested in the following titles: Medical Device Coatings and Surface Modification Technologies Market mRNA Synthesis and Manufacturing Services Market You may also like to learn what our experts are sharing in Roots educational series: Applications of Blockchain in Various Sectors: An Introduction Intracellular Drug Delivery â Future Potential About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #TILTherapiesMarketSize #TILTherapiesMarketGrowth #TILimmunotherapies #TILbasedproducts #TILMarket ]]> https://old.p-tweets.com/viewupdate.php?id=163893 https://old.p-tweets.com/viewupdate.php?id=163893


Posted by: jameshebrew
On Fri, 12 May 2023 06:32:55 +0000


]]> jameshebrew <![CDATA[Analysis of mRNA Synthesis and Manufacturing Services market Strategies and Forecasts to 2035 Owing to the recent success and growing pipeline of mRNA-based products in the market, mRNA, as a therapeutic agent, has gained significant traction from the medical community. However, due to challenges, such as high capital requirement, stringent regulations and lack of technical expertise, outsourcing has become a preferred business model and CMOs are upgrading their existing capabilities and service portfolios to meet the increased demand for mRNA-based products. A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Type of Product  Drug substances (APIs)  Drug products (FDFs)  Application Area  mRNA-based vaccines  mRNA-based therapeutics  Therapeutic Area  Infectious diseases  Oncological disorders  Other diseases  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa  Rest of the World The mRNA Synthesis and Manufacturing Services Market (2nd Edition), 2022 â 2035 report features the following companies, which we identified to be key players in this domain:  Aldevron  APExBIO  Biomay  bioSYNTHESIS  CELLSCRIPT  eTheRNA  Eurogentec  Jena Biosciences  New England Biolabs  Thermo Fisher Scientific  TriLink BioTechnologies Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape: mRNA Custom Synthesis Service Providers 5. Company Competitiveness Analysis: mRNA Custom Synthesis Service Providers 6. Market Landscape: mRNA Contract Manufacturing Service Providers 7. Company Competitiveness Analysis: mRNA Contract Manufacturing Service Providers 8. Market Landscape: mRNA Synthesis Kit Providers 9. Product Competitiveness Analysis: mRNA Synthesis Kits 10. Company Profiles: mRNA Synthesis and Manufacturing Service Providers 11. Company Profiles: mRNA Synthesis Kit Providers 12. Clinical Trial Analysis 13. Partnership and Collaborations 14. Likely Partners Analysis 15. Big Pharma Initiatives 16. Market Forecast 17. Appendix 1: Tabulated Data 18. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/mrna-synthesis-and-manufacturing-market.html You may also be interested in the following titles: Pharmaceutical Polymers / Medical Polymers Market Gene Switch Market You may also like to learn what our experts are sharing in Roots educational series: Digital Therapies: The âDigital Pillsâ of current generation Medical Device Coatings and Modification Technologies About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #mRNASynthesisandManufacturingServicesMarketTrends #mRNASynthesisandManufacturingServicesMarketGrowth #mRNAcontractmanufacturing #mRNASynthesis #mRNAmanufacturing ]]> https://old.p-tweets.com/viewupdate.php?id=163750 https://old.p-tweets.com/viewupdate.php?id=163750


Posted by: jameshebrew
On Thu, 11 May 2023 05:26:38 +0000


]]> jameshebrew